الوصف
Psychiatric disorder outcomes including depression and anxiety from EPA-predominant versus DHA-predominant supplement trials are compared.
Figure 25
Source Paper
Do Eicosapentaenoic Acid and Docosahexaenoic Acid Have the Potential to Compete against Each Other?Cite This Figure
![Figure 25: Psychiatric disorder outcomes including depression and anxiety from EPA-predominant versus DHA-predominant supplement trials are compared.]() > Source: Anandita Pal et al. "Do Eicosapentaenoic Acid and Docosahexaenoic Acid Have the Potential to Compete ." *Nutrients*, 2020. PMID: [33276463](https://pubmed.ncbi.nlm.nih.gov/33276463/)
<figure> <img src="" alt="Psychiatric disorder outcomes including depression and anxiety from EPA-predominant versus DHA-predominant supplement trials are compared." /> <figcaption>Figure 25. Psychiatric disorder outcomes including depression and anxiety from EPA-predominant versus DHA-predominant supplement trials are compared.<br> Source: Anandita Pal et al. "Do Eicosapentaenoic Acid and Docosahexaenoic Acid Have the Potential to Compete ." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33276463/">33276463</a></figcaption> </figure>